PLB-1001

PLB-1001 (Bozitinib, PLB1001, CBI-3103, CBT-101) is a potent, highly selective, ATP-competitive, BBB-permeable MET kinase inhibitor, potently inhibits MET activity by 95.1% at 2 uM.

Target : c-Met/HGFR

CAS Number : 1440964-89-5

Formula Weight : 424.391

Molecular Formula : C20H15F3N8

Purity : 98.25% (HPLC)

Storage : (-20?)

Shipping Conditions : With Ice Pack

Stability : ? 2 years

Research use only, not for human use.